Google Parent Alphabet and French Drugmaker Sanofi Set Up Diabetes Joint Venture

Share on Facebook Tweet Share Reddit Comment
Google Parent Alphabet and French Drugmaker Sanofi Set Up Diabetes Joint Venture
Highlights
  • The new venture, Onduo will initially focus on the type 2 diabetes
  • Sanofi had invested $248 million in the joint venture with Alphabet
  • Alphabet had earlier partnered GSK for a life science unit

Google and French pharmaceutical giant Sanofi announced Monday a new joint venture focused on diabetes care.

The tie up between the drug maker and Verily, the health subsidiary of Google's parent company Alphabet, will focus on treatments for people living with the chronic disease.

Details on what the company's products will look like - or when they will reach the market - were scant, but they will combine the drugmaker's clinical know-how with the tech company's background in analytics and mini devices, a joint statement said.

"As it will initially consist of connecting already existing products, we can expect the first innovations to arrive more quickly than if it was a pharmaceutical research programme starting from scratch," the head of Sanofi's diabetes business Stefan Oelrich told AFP.

The venture, called Onduo, will initially focus on type two diabetes, the more common form of the disease. The prevalence of type two diabetes is soring globally as obesity rates also rise.

Eventually, Onduo plans to expand its business to type one diabetes, an autoimmune disorder that requires daily insulin, and eventually those at risk of developing the disease.

Sanofi has invested $248 million in the venture, with Verily putting in an "equivalent" amount, according to Oelrich.

The new company will be based in the US town of Cambridge, near Boston, the epicentre of the global biotechnology and the pharmaceutical industries, where Sanofi already has a presence.

Verily was born out of Google's X lab and has previously partnered with other pharma giants, including Johnson & Johnson to develop surgical robots and in a bioelectronic venture with UK-based GlaxoSmithKline.

Comments

For the latest tech news and reviews, follow Gadgets 360 on Twitter, Facebook, and subscribe to our YouTube channel.

Further reading: Sanofi, Science, Alphabet, Google
Lenovo A6600, A6600 Plus, A7700 Phones With Reliance Jio Offers Launched
 
 

Advertisement

 

Advertisement

© Copyright Red Pixels Ventures Limited 2019. All rights reserved.